H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on PepGen (PEPG) to $14 from $16 and keeps a Buy rating on the shares after the company announced that the results from the PGN-EDO51 cohort from the CONNECT1 cohort are scheduled to readout in Q3.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEPG: